Family Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.13M | Sell |
4,066
-138
| -3% | -$72.5K | 0.32% | 72 |
|
2025
Q1 | $2.67M | Buy |
4,204
+80
| +2% | +$50.7K | 0.44% | 60 |
|
2024
Q4 | $2.94M | Buy |
4,124
+124
| +3% | +$88.3K | 0.47% | 51 |
|
2024
Q3 | $4.2M | Sell |
4,000
-2,650
| -40% | -$2.79M | 0.69% | 36 |
|
2024
Q2 | $6.99M | Buy |
6,650
+374
| +6% | +$393K | 1.23% | 19 |
|
2024
Q1 | $6.04M | Buy |
6,276
+577
| +10% | +$555K | 1.11% | 22 |
|
2023
Q4 | $5.01M | Sell |
5,699
-443
| -7% | -$389K | 1.04% | 25 |
|
2023
Q3 | $5.05M | Sell |
6,142
-63
| -1% | -$51.8K | 1.15% | 23 |
|
2023
Q2 | $4.46M | Sell |
6,205
-86
| -1% | -$61.8K | 0.98% | 26 |
|
2023
Q1 | $5.17M | Buy |
6,291
+320
| +5% | +$263K | 1.19% | 25 |
|
2022
Q4 | $4.31M | Sell |
5,971
-65
| -1% | -$46.9K | 1.05% | 28 |
|
2022
Q3 | $4.16M | Sell |
6,036
-66
| -1% | -$45.5K | 1.07% | 23 |
|
2022
Q2 | $3.61M | Sell |
6,102
-269
| -4% | -$159K | 0.97% | 28 |
|
2022
Q1 | $4.45M | Sell |
6,371
-13
| -0.2% | -$9.08K | 1.23% | 23 |
|
2021
Q4 | $4.03M | Buy |
6,384
+119
| +2% | +$75.2K | 1.05% | 31 |
|
2021
Q3 | $3.79M | Buy |
6,265
+61
| +1% | +$36.9K | 1.05% | 31 |
|
2021
Q2 | $3.47M | Sell |
6,204
-882
| -12% | -$493K | 0.92% | 34 |
|
2021
Q1 | $3.35M | Buy |
7,086
+63
| +0.9% | +$29.8K | 1.05% | 31 |
|
2020
Q4 | $3.39M | Buy |
7,023
+1,796
| +34% | +$868K | 1.16% | 31 |
|
2020
Q3 | $2.93M | Sell |
5,227
-1,457
| -22% | -$816K | 1.28% | 26 |
|
2020
Q2 | $4.17M | Sell |
6,684
-1,920
| -22% | -$1.2M | 1.7% | 15 |
|
2020
Q1 | $4.2M | Sell |
8,604
-112
| -1% | -$54.7K | 2.1% | 10 |
|
2019
Q4 | $3.27M | Sell |
8,716
-14
| -0.2% | -$5.26K | 1.13% | 29 |
|
2019
Q3 | $2.42M | Sell |
8,730
-7
| -0.1% | -$1.94K | 0.9% | 35 |
|
2019
Q2 | $2.74M | Buy |
8,737
+134
| +2% | +$41.9K | 1.07% | 31 |
|
2019
Q1 | $3.53M | Buy |
8,603
+4,087
| +91% | +$1.68M | 1.52% | 15 |
|
2018
Q4 | $1.69M | Buy |
+4,516
| New | +$1.69M | 0.71% | 42 |
|